Crinetics Pharmaceuticals, Inc. Costs and Expenses
Crinetics Pharmaceuticals, Inc. (CRNX) reported Costs and Expenses of $157.58 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. costs and expenses for the quarter ending 2026-06-30 was $157.58M, a 21.08% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. costs and expenses for the quarter ending 2026-03-31 was $151.11M, a 35.20% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. costs and expenses for the quarter ending 2025-06-30 was $130.14M.
- Crinetics Pharmaceuticals, Inc. costs and expenses for the quarter ending 2025-03-31 was $111.77M.
- Crinetics Pharmaceuticals, Inc. costs and expenses for fiscal 2025 was $524.47M, a 54.30% increase from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. costs and expenses for fiscal 2024 was $339.89M, a 49.98% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. costs and expenses for fiscal 2023 was $226.62M.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 12 month |
|---|---|---|---|
| 2026-06-30 | $157.58M 10-Q · filed 2026-08-03 | $308.69M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $151.11M 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $524.47M 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $130.14M 10-Q · filed 2026-08-03 | $241.91M 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $111.77M 10-Q · filed 2026-05-07 | ||
| 2024-12-31 | $339.89M 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $226.62M 10-K · filed 2026-02-26 |